C07K 2317/22
From camelids
Official title: from camelids, e.g. camel, llama or dromedary
C07K2317/22 (From camelids) appears on 788 US grants and 1,782 published applications in this corpus.
Search patents in C07K- Granted patents
- 788
- Published applications
- 1,782
- Assignees
- 709
- Inventors
- 3,091
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 1 | 4 |
| 2003 | 2 | 8 |
| 2004 | 2 | 8 |
| 2005 | 1 | 22 |
| 2006 | 3 | 20 |
| 2007 | 3 | 17 |
| 2008 | 4 | 13 |
| 2009 | 3 | 23 |
| 2010 | 12 | 44 |
| 2011 | 4 | 54 |
| 2012 | 11 | 33 |
| 2013 | 15 | 35 |
| 2014 | 21 | 49 |
| 2015 | 30 | 59 |
| 2016 | 36 | 54 |
| 2017 | 50 | 84 |
| 2018 | 61 | 92 |
| 2019 | 47 | 85 |
| 2020 | 51 | 91 |
| 2021 | 63 | 123 |
| 2022 | 56 | 145 |
| 2023 | 49 | 151 |
| 2024 | 97 | 210 |
| 2025 | 92 | 200 |
| 2026 | 68 | 157 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Aggrecan binding immunoglobulins6 Oct 2026US 12,753,224 B2Ablynx N. V.
- Compositions and methods for genetically-encoded high voltage-activated calcium channel blockers using engineered ubiquitin ligases6 Oct 2026US 12,753,228 B2The Trustees of Columbia University in the City of New York
- Luciferase linked immunosorbent assay6 Oct 2026US 12,753,245 B2Institut Pasteur
- Targeting of human interferon antagonists22 Sep 2026US 12,741,998 B2Centre Hospitalier Regional Universitaire De Montpellier
- Immunoglobulin variable domains1 Sep 2026US 12,723,072 B2Ablynx N. V.
- Targeted engineered interferon and uses thereof8 Oct 2026US 2026/0308221 A1Orionis Biosciences BV
- Il12rb2 binding molecules and methods of use8 Oct 2026US 2026/0308265 A1Synthekine, Inc.
- Slc4a1 (band 3) binding single domain antibodies for increased blood retention8 Oct 2026US 2026/0308272 A1
- Methods and compositions for in situ identification of protein-nucleic acid interaction sites8 Oct 2026US 2026/0308279 A1The Regents of the University of California
- Sequence-based high throughput method generating camelids antibodies to cover broad epitopes with high-resolution8 Oct 2026US 2026/0308807 A1Zhejiang Nanomab Technology Center Co. Ltd.
Most cited
By later US patents
- Immunoglobulins devoid of light chains285US 6,005,079 AVrije Universiteit Brussels · 1999
- Immunoglobulins devoid of light chains131US 5,759,808 AVrije Universiteit Brussel · 1998
- Protein scaffolds for antibody mimics and other binding proteins125US 7,115,396 B2Compound Therapeutics, Inc. · 2006
- Immunoglobulins devoid of light chains117US 5,840,526 AVrije Universiteit Brussel · 1998
- Immunoglobulins devoid of light chains116US 6,015,695 AVrije Universiteit Brussel · 2000